Sichenzia Ross Friedman Ference LLP Represents Cynata on A$5.0M Private Placement
Press Release – New York – July 17, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that acted as US counsel to Australian-based stem cell and regenerative medicine provider Cynata Therapeutics Limited (ASX: CYP) in connection with a A$5 million private placement. The offering consisted of 6,670,000 shares of Cynata’s common stock and warrants priced at A$0.75 per share.
The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia and David Manno. H.C. Wainwright & Co. acted as the sole placement agent on the offering.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Sichenzia Ross Ference Kesner LLP Represents MoneyOnMobile, Inc., in a $5 Million Private Placement - February 12, 2018
- Sichenzia Ross Ference Kesner LLP Represents MoneyOnMobile, Inc., in $7.6 Million of Private Placements - February 8, 2018
- Sichenzia Ross Ference Kesner LLP Represents Roth Capital Partners and Brookline Securities in a $5.5 Million Public Offering of QBIO Med. - February 1, 2018